1. 2022
  2. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

    van der Straten, K., Guerra, D., van Gils, M. J., Bontjer, I., Caniels, T. G., van Willigen, H. D. G., Wynberg, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., van Rijswijk, J., Olijhoek, W., Liesdek, M. H., Lavell, A. H. A., Appelman, B., Sikkens, J. J., Bomers, M. K., Han, A. X., Nichols, B. E., Prins, M., & 7 othersVennema, H., Reusken, C., de Jong, M. D., de Bree, G. J., Russell, C. A., Eggink, D. & Sanders, R. W., 13 Sep 2022, In: Immunity. 55, 9, p. 1725-1731.e4

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset

    RECoVERED Study Group, 24 Aug 2022, In: Clinical infectious diseases. 75, 1, p. e482-e490

    Research output: Contribution to journalArticleAcademicpeer-review

  4. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study

    the RECoVERED Study Group, 30 Jul 2022, In: Vaccine. 40, 32, p. 4424-4431 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study

    Verveen, A., Wynberg, E., van Willigen, H. D. G., Boyd, A., de Jong, M. D., de Bree, G., Davidovich, U., Lok, A., Moll van Charante, E. P., Knoop, H., Prins, M., Nieuwkerk, P., Agard, I., Ayal, J., Cavdar, F., Craanen, M., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., & 36 othersHartman, J., Koedoot, N., Leenstra, T., Lebbink, R., Loomans, D., Makowska, A., du Maine, T., de Man, I., Matser, A., van der Meij, L., van Polanen, M., Oud, M., Reid, C., Storey, L., van Wijk, M., van den Aardweg, J., van Assem, J., van Beek, M., Blankert, T., Dijkstra, M., Figaroa, O., Frenkel, L., van Gils, M., van Haga, J., Han, X., Harskamp-Holwerda, A., Hazenberg, M., Hidad, S., de Jong, N., Kootstra, N., Kuijt, L., Russell, C., van der Straten, K., van der Veen, A., Verkaik, B. & Visser, G-R., 1 May 2022, In: Open forum infectious diseases. 9, 5, ofac127.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern

    van Gils, M. J., van Willigen, H. D. G., Wynberg, E., Han, A. X., van der Straten, K., Burger, J. A., Poniman, M., Oomen, M., Tejjani, K., Bouhuijs, J. H., Verveen, A., Lebbink, R., Dijkstra, M., Appelman, B., Lavell, A. H. A., Caniels, T. G., Bontjer, I., van Vught, L. A., Vlaar, A. P. J., Sikkens, J. J., & 32 othersBomers, M. K., Russell, C. A., Kootstra, N. A., Sanders, R. W., Prins, M., de Bree, G. J., de Jong, M. D., RECoVERED Study Group, Agard, I., Ayal, J., Boyd, A., Cavdar, F., Craanen, M., Davidovich, U., Deuring, A., van Dijk, A., Ersan, E., del Grande, L., Hartman, J., Koedoot, N., van den Aardweg, J., Boeser-Nunnink, B., Moll van Charante, E., van Dort, K., Hidad, S., Jurriaans, S., Knoop, H., Lok, A., Maurer, I., Nieuwkerk, P., van Nuenen, A. & Matser, A., 18 Jan 2022, In: Cell Reports Medicine. 3, 1, 100486.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2021
  8. Hospitalisation rates differed by city district and ethnicity during the first wave of COVID-19 in Amsterdam, The Netherlands

    Coyer, L., Wynberg, E., Buster, M., Wijffels, C., Prins, M., Schreijer, A., van Duijnhoven, Y. T. H. P., van Dam, A. P., van der Lubben, M. & Leenstra, T., 1 Dec 2021, In: BMC public health. 21, 1, 1721.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

    Amsterdam UMC COVID-19 S3/HCW study group, 23 Nov 2021, In: eLife. 10, e70330.

    Research output: Contribution to journalArticleAcademicpeer-review

  10. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination

    Caniels, T. G., Bontjer, I., van der Straten, K., Poniman, M., Burger, J. A., Appelman, B., Lavell, H. A. A., Oomen, M., Godeke, G-J., Valle, C., Mögling, R., van Willigen, H. D. G., Wynberg, E., Schinkel, M., van Vught, L. A., Guerra, D., Snitselaar, J. L., Amsterdam UMC COVID-19 S3/HCW study group, Chaturbhuj, D. N., Martin, I. C., & 9 othersMoore, J. P., de Jong, M. D., Reusken, C., Sikkens, J. J., Bomers, M. K., de Bree, G. J., van Gils, M. J., Eggink, D. & Sanders, R. W., 1 Sep 2021, In: Science advances. 7, 36, p. eabj5365 eabj5365.

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 11923129